<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Past events: agendas, slidedecks, recordings</title>

<script src="site_libs/header-attrs-2.11/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/bootstrap.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.11.4/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>









<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark it active
  menuAnchor.tab('show');

  // if it's got a parent navbar menu mark it active as well
  menuAnchor.closest('li.dropdown').addClass('active');

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "&#xe258;";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Basel Biometrics Society</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    About BBS
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="purpose.html">Purpose</a>
    </li>
    <li>
      <a href="board.html">BBS board</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Upcoming events
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="events_upcoming.html">Announcements of upcoming events</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Past seminars
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="events_past.html">Agendas, slidedecks, and recordings of past BBS seminars</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-expanded="false">
    Past trainings
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="trainings_past.html">Agendas, slidedecks, and recordings of past BBS training events</a>
    </li>
  </ul>
</li>
<li>
  <a href="additional_docs.html">Additional documents</a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Past events: agendas, slidedecks, recordings</h1>
<h4 class="date">Last change: 11 August, 2022</h4>

</div>


<div id="on-market-approval-and-market-access-breaking-the-linear-thinking-or-how-to-innovate-in-a-crowded-space" class="section level1 unnumbered">
<h1 class="unnumbered">15.07.2022: On market approval and market access: Breaking the linear thinking or how to innovate in a crowded space?</h1>
<p><a href="talks/20220715/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/t/1_moqs7fc2">Recording</a></p>
<table>
<colgroup>
<col width="35%" />
<col width="21%" />
<col width="24%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Frank Bretz</td>
<td align="left">Novartis</td>
<td align="left">Welcome</td>
<td align="left"><a href="talks/20220715/1_Bretz.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Anja Schiel (starts at 00:04:00)</td>
<td align="left">NOMA &amp; EMA</td>
<td align="left">Start thinking HTA early</td>
<td align="left"><a href="talks/20220715/2_Schiel.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Nigel Yateman (01:01:15)</td>
<td align="left">Novartis</td>
<td align="left">Challenges in developing next generation CAR-T</td>
<td align="left"><a href="talks/20220715/3_Yateman.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Iain Bennett (01:22:30)</td>
<td align="left">Roche</td>
<td align="left">No comparators no problem?</td>
<td align="left"><a href="talks/20220715/4_Bennett.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Karen Facey (01:42:50)</td>
<td align="left">University of Edinburgh and self-employed</td>
<td align="left">Comments to introduce panel discussion</td>
<td align="left"><a href="talks/20220715/5_Facey.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Speakers + Gorana Capkun, Lilla di Scala, Andrew Thomson (01:58:15)</td>
<td align="left"></td>
<td align="left">Panel discussion</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-efspi-seminar-registry-studies-and-hta" class="section level1 unnumbered">
<h1 class="unnumbered">23.06.2022: BBS / EFSPI Seminar Registry studies and HTA</h1>
<p><a href="talks/20220623/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/t/1_yynoypov">Recording</a></p>
<table>
<colgroup>
<col width="12%" />
<col width="22%" />
<col width="50%" />
<col width="15%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Fred Sorenson</td>
<td align="left">Xcenda, Switzerland</td>
<td align="left">Welcome</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Eric Faulkner and Omar Dabbous</td>
<td align="left">Novartis Gene Therapies, USA</td>
<td align="left">An open dialog on the issues faced and lessons learned with respect to Novartis Gene Therapies’ Spinal Muscular Atrophy (SMA) registries</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Entela Xoxi</td>
<td align="left">Università Cattolica del Sacro Cuore, Italy</td>
<td align="left">AIFA registries: past and current &amp; upcoming challenges</td>
<td align="left"><a href="talks/20220623/3_Xoxi.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Jinma Ren and Friedhelm Leverkus</td>
<td align="left">Pfizer, USA and Pfizer, Germany</td>
<td align="left">Issues in the design and analysis of registry-based studies for regulatory and HTA purposes</td>
<td align="left"><a href="talks/20220623/4_Ren_Leverkus.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Mei Yang</td>
<td align="left">Happy Life Technology, China &amp; USA</td>
<td align="left">Registries in China: Guidelines, trends and new technologies</td>
<td align="left"><a href="talks/20220623/5_Yang.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Rossella Di Bidino</td>
<td align="left">Fondazione Policlinico Universitario Agostino Gemelli, Italy</td>
<td align="left">Hospital Perspective on using Registry Data for HTA</td>
<td align="left"><a href="talks/20220623/6_DiBidino.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Kirk Geale</td>
<td align="left">Quantify Research, Sweden</td>
<td align="left">Case studies using Registry Data for HTA in Scandinavia</td>
<td align="left"><a href="talks/20220623/7_Geale.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Kat Belendiuk</td>
<td align="left">Genentech, USA</td>
<td align="left">FlywheelMS Case Study - A complete web-based digital registry of 5,000 patients with Multiple Sclerosis in the USA</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar-transforming-drug-development-and-assembly" class="section level1 unnumbered">
<h1 class="unnumbered">24.05.2022: BBS Spring Seminar Transforming drug development and Assembly</h1>
<p><a href="talks/20220524/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Spring%20Seminar%20Transforming%20drug%20development%20and%20Assembly%2024%20May%202022%20-%20Recording%20part%201/1_fqboxp8j">Recording</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Spring%20Seminar%20Transforming%20drug%20development%20and%20Assembly%2024%20May%202022%20-%20Recording%20part%202/1_oazfwu9q">Recording 2</a></p>
<table>
<colgroup>
<col width="44%" />
<col width="17%" />
<col width="16%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Uli Burger</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Pierre Verweij, Guy Braunstein, Colin Terry, Pavi Rallapalli, Dominik Heinzmann, Lisa Hampson, Marc Vandemeulebroecke, Heinz Schmidli, Sebastian Weber, Laurent Essioux</td>
<td align="left">Idorsia Pharmaceuticals, Deloitte, Novo Nordisk, Novartis, Roche</td>
<td align="left">BBS Spring Seminar Transforming drug development and assembly</td>
<td align="left"><a href="talks/20220524/2_BBS_Spring_Seminar_and_Assembly_24MAY2022_Masterslides.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="graphical-approaches-to-multiple-test-problems" class="section level1 unnumbered">
<h1 class="unnumbered">29.03.2022: Graphical approaches to multiple test problems</h1>
<p><a href="talks/20220329/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Seminar%20Graphical%20approaches%20to%20multiple%20test%20problems%2029%20Mar%202022%20-%20Part%201/1_6zf98l0r">Recording</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS+Seminar+Graphical+approaches+to+multiple+test+problems+29+Mar+2022+-+Part+2/1_2i02bql4">Recording 2</a></p>
<table>
<colgroup>
<col width="25%" />
<col width="12%" />
<col width="31%" />
<col width="29%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Marc Vandemeulebroecke</td>
<td align="left">Novartis, Basel</td>
<td align="left">Welcome</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Ekkehard Glimm, Frank Bretz &amp; Dong Xi</td>
<td align="left">Novartis &amp; Gilead</td>
<td align="left">Graphical approaches to multiple test problems</td>
<td align="left"><a href="talks/20220329/2_Glimm_Bretz_Xi.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="machine-learning-in-clinical-drug-development" class="section level1 unnumbered">
<h1 class="unnumbered">21.02.2022: Machine Learning in clinical drug development</h1>
<p><a href="talks/20220221/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/t/1_qasjwd4f">Recording</a></p>
<table>
<colgroup>
<col width="21%" />
<col width="11%" />
<col width="34%" />
<col width="32%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Markus Lange, Lorenz Uhlmann</td>
<td align="left">Novartis, Basel</td>
<td align="left">Machine Learning in clinical drug development</td>
<td align="left"><a href="talks/20220221/1_Lange_Uhlmann.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Markus Lange, Lorenz Uhlmann</td>
<td align="left">Novartis, Basel</td>
<td align="left">Questions from the chat, with answers</td>
<td align="left"><a href="talks/20220221/chat_questions.xlsx">link</a></td>
</tr>
<tr class="odd">
<td align="left">Markus Lange, Lorenz Uhlmann</td>
<td align="left">Novartis, Basel</td>
<td align="left">R exercises</td>
<td align="left"><a href="talks/20220221/exercises.R">link</a></td>
</tr>
<tr class="even">
<td align="left">Markus Lange, Lorenz Uhlmann</td>
<td align="left">Novartis, Basel</td>
<td align="left">Dataset used for exercises</td>
<td align="left"><a href="talks/20220221/dat.csv">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="joint-bbsbes-webinar-covid-19-pandemic-and-how-we-deal-with-data" class="section level1 unnumbered">
<h1 class="unnumbered">27.07.2021: Joint BBS/BES Webinar COVID-19 pandemic and how we deal with data</h1>
<p><a href="talks/20210727/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS+virtual+seminarA+COVID-19+pandemic+%26+how+we+deal+with+data/1_lguf3l7i">Recording</a></p>
<table>
<colgroup>
<col width="12%" />
<col width="19%" />
<col width="47%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Hans Ulrich Burger</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Tim Friede</td>
<td align="left">University Medical Center Göttingen</td>
<td align="left">Data and Statistics as a basis for decision making: A discussion of the Corona pandemic</td>
<td align="left"><a href="talks/20210727/2_Friede.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Thorsten Lehr</td>
<td align="left">Saarland University</td>
<td align="left">Forecasting: What do we learn?</td>
<td align="left"><a href="talks/20210727/3_Lehr.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Thierry Van Effelterre</td>
<td align="left">J&amp;J</td>
<td align="left">Vaccination trials: What do we know about long-term efficacy measures and other questions</td>
<td align="left"><a href="talks/20210727/4_Effelterre.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Fei Chen</td>
<td align="left">Janssen</td>
<td align="left">Statistical Considerations Underlying a COVID-19 Vaccine phase 3 design</td>
<td align="left"><a href="talks/20210727/5_Chen.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="joint-efspibbs-meeting-precision-innovative-medicine-and-health-technology-assessment" class="section level1 unnumbered">
<h1 class="unnumbered">28.06.2021: Joint EFSPI/BBS Meeting Precision &amp; Innovative Medicine and Health Technology Assessment</h1>
<p><a href="talks/20210628/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/t/1_794su8nj">Recording</a></p>
<table>
<colgroup>
<col width="19%" />
<col width="16%" />
<col width="48%" />
<col width="15%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Fred Sorensen</td>
<td align="left">Xcenda</td>
<td align="left">Welcome</td>
<td align="left"><a href="talks/20210628/1_Sorensen.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Dan O’Connor</td>
<td align="left">MHRA, UK</td>
<td align="left">The UK’s Innovative Licensing and Access Pathway (ILAP) for medicines – A joint MHRA, NICE &amp; SMC initiative</td>
<td align="left"><a href="talks/20210628/2_OConnor.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Karen Facey</td>
<td align="left">University of Edinburgh</td>
<td align="left">IMPACT HTA - Recommendations for Developing Rare Disease Treatments</td>
<td align="left"><a href="talks/20210628/3_Facey.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Paul Cislo, Jinma Ren and Joseph C. Cappelleri</td>
<td align="left">Pfizer</td>
<td align="left">Adjusting Global Survival to Make Results More Relevant and Generalizable to Local Markets</td>
<td align="left"><a href="talks/20210628/4_Cislo.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Marc Buyse</td>
<td align="left">IDDI and University of Hasselt, Belgium</td>
<td align="left">Net benefit and correlation between benefit and harms</td>
<td align="left"><a href="talks/20210628/5_Buyse.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mark Belger and Marie-Ange Paget</td>
<td align="left">Eli Lilly UK &amp; France</td>
<td align="left">Closing the efficacy to effectiveness gap: Generalizing from RCTs to real world populations</td>
<td align="left"><a href="talks/20210628/6_Belger.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Kirsten Herrmann</td>
<td align="left">Exact Sciences, Germany</td>
<td align="left">Assessments and reimbursement of gene expression signature tests in Europe</td>
<td align="left"><a href="talks/20210628/7_Herrmann.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Janneke Boersma</td>
<td align="left">Roche, Netherlands</td>
<td align="left">Bridging the gap between Regulatory &amp; HTA approval for Precision Medicine therapies: a case study from the Netherlands</td>
<td align="left"><a href="talks/20210628/8_Boersma.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-webinar-impact-of-the-covid-19-pandemic-on-clinical-trials" class="section level1 unnumbered">
<h1 class="unnumbered">16.06.2021: BBS Webinar Impact of the COVID-19 Pandemic on Clinical Trials</h1>
<p><a href="talks/20210616/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Seminar_Impact%20of%20the%20COVID-19%20pandemic%20on%20clinical%20trials_16JUN2021_Recording/1_29yj4985">Recording</a></p>
<table>
<colgroup>
<col width="9%" />
<col width="21%" />
<col width="48%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Anja Schiel</td>
<td align="left">Chair Scientific Advice Working Party, EMA</td>
<td align="left">Overview on early experience of the impact of Covid-19 pandemic on clinical trials</td>
<td align="left"><a href="talks/20210616/1_Schiel.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Paul Delmar</td>
<td align="left">Roche, Basel</td>
<td align="left">COVID-19 pandemics : Impact on Clinical Trials in a chronic progressing disease</td>
<td align="left"><a href="talks/20210616/2_Delmar.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Eva Hua</td>
<td align="left">Novartis, Basel</td>
<td align="left">Hypothetical strategy for a case study affected by COVID-19 pandemic</td>
<td align="left"><a href="talks/20210616/3_Hua.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Kelly Van Lancker</td>
<td align="left">Ghent University</td>
<td align="left">The hypothetical estimand and its potential estimators in clinical trials impacted by COVID-19</td>
<td align="left"><a href="talks/20210616/4_VanLancker.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-webinar-statistical-challenges-in-the-clinical-development-of-car-t-cell-therapies" class="section level1 unnumbered">
<h1 class="unnumbered">22.03.2021: BBS Webinar Statistical challenges in the clinical development of CAR T-cell therapies</h1>
<p><a href="talks/20210322/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Seminar_%20CAR-T%20Cell%20Therapies_22MAR2021_Recording/1_jl5ndejn">Recording</a></p>
<table>
<colgroup>
<col width="17%" />
<col width="14%" />
<col width="42%" />
<col width="25%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Roland Marion-Gallois</td>
<td align="left">BMS, Switzerland</td>
<td align="left">Welcome and Introduction</td>
<td align="left"><a href="talks/20210322/01_Marion-Gallois.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Caroline Aarber Bath</td>
<td align="left">CHUV, Switzerland</td>
<td align="left">Introduction to Cell Therapies: A Clinical Perspective</td>
<td align="left"><a href="talks/20210322/02_Arber.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Elina Asikanius</td>
<td align="left">FIMEA, Finland</td>
<td align="left">Perspective from EMA</td>
<td align="left"><a href="talks/20210322/03_Asikanius.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Zhenzhen Xu</td>
<td align="left">FDA, USA</td>
<td align="left">Perspective from FDA</td>
<td align="left"><a href="talks/20210322/04_Xu.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Khadija Rantell</td>
<td align="left">MHRA, UK</td>
<td align="left">Phase 2 / Phase 3, Treatment effect or therapeutic strategy effect?</td>
<td align="left"><a href="talks/20210322/05_Rantell.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Alessandro Previtali</td>
<td align="left">BMS, Switzerland</td>
<td align="left">Phase 2 / Phase 3, Estimands in the context of cell therapy development</td>
<td align="left"><a href="talks/20210322/06_Previtali.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Nigel Yateman</td>
<td align="left">Novartis, Switzerland</td>
<td align="left">Challenges for new CAR-T therapies</td>
<td align="left"><a href="talks/20210322/07_Yateman.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Oriana Ciani</td>
<td align="left">Università Bocconi, Italy</td>
<td align="left">Introduction on Post-Approval challenges, reimbursement and HTA assessments</td>
<td align="left"><a href="talks/20210322/08_Ciani.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Andrea Smith</td>
<td align="left">G-BA, Germany</td>
<td align="left">HTA-Perspective on the assessment of CAR-T-Cell Therapies</td>
<td align="left"><a href="talks/20210322/09_Smith.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Marcelo Pasquini and Zhenuan Hu</td>
<td align="left">CIBMTR, USA</td>
<td align="left">CAR-T cell therapy registries</td>
<td align="left"><a href="talks/20210322/10_Pasquini.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="graphics-for-decision-making-in-biomedical-research-and-drug-development" class="section level1 unnumbered">
<h1 class="unnumbered">08.03.2021: Graphics for decision-making in biomedical research and drug development</h1>
<p><a href="talks/20210308/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS%20Seminar_%20Graphics%20for%20decision-making_08MAR2021_Recording/1_giyubkcv">Recording</a></p>
<table style="width:100%;">
<colgroup>
<col width="29%" />
<col width="7%" />
<col width="46%" />
<col width="16%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Dominik Heinzmann</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Hannah Diehl and Tamara Broderick / Andy Stein and Niladri Roy Chowdhury</td>
<td align="left">MIT and Novartis</td>
<td align="left">The “See”-Value App: Visual Decision Making for Drug Development</td>
<td align="left"><a href="talks/20210308/2_Diehl.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Neil McQuarrie</td>
<td align="left">Flatiron</td>
<td align="left">Better understanding and reacting on impact of COVID-19 on RWD collection by combining statistics with visualization</td>
<td align="left"><a href="talks/20210308/3_McQuarrie.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Tadeusz Lewandowski</td>
<td align="left">Roche, Basel</td>
<td align="left">Interactive clinical study visualisation in enabling the faster decision making</td>
<td align="left"><a href="talks/20210308/4_Lewandowski.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Markus Lange</td>
<td align="left">Novartis, Basel</td>
<td align="left">Unraveling a single number – using graphics to explain Probability of Success</td>
<td align="left"><a href="talks/20210308/5_Lange.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Anne-Marie Meyer</td>
<td align="left">Roche, Basel</td>
<td align="left">Population Level Analytics for pandemic response: Predicting vaccine uptake and vaccine hesitancy</td>
<td align="left"><a href="talks/20210308/6_Meyer.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Giusi Moffa</td>
<td align="left">University of Basel</td>
<td align="left">Closure</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="joint-efspi-bbs-webinar-the-application-of-estimands-from-a-neuroscience-perspective" class="section level1 unnumbered">
<h1 class="unnumbered">03.11.2020: Joint EFSPI / BBS Webinar: The application of estimands from a Neuroscience perspective</h1>
<p><a href="talks/20201103/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/Joint+EFSPI+++BBS+SeminarA+%22The+application+of+estimands+from+a+Neuroscience+perspective%22-20201103+1202-1_202243567/0_4g72gvb4">Recording</a></p>
<table>
<colgroup>
<col width="15%" />
<col width="18%" />
<col width="50%" />
<col width="15%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Hans Ulrich Burger</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome and introduction to the estimand framework</td>
<td align="left"><a href="talks/20201103/1_Burger.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Nikolaos Sfikas</td>
<td align="left">Novartis, Basel</td>
<td align="left">Outline of an estimand strategy in MS</td>
<td align="left"><a href="talks/20201103/2_Sfikas.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Mette Krog Josiassen and Peter Quarg</td>
<td align="left">Lundbeck and Novartis</td>
<td align="left">Outline of an estimand proposal in migraine prevention and neuropathic pain</td>
<td align="left"><a href="talks/20201103/3_Krog.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Paul Delmar</td>
<td align="left">Roche, Basel</td>
<td align="left">Using the Estimand Framework to address challenges in AD clinical trial with a closer look at the hypothetical strategy</td>
<td align="left"><a href="talks/20201103/4_Delmar.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Carrie Li</td>
<td align="left">Roche, Basel</td>
<td align="left">Estimands in Huntington’s disease</td>
<td align="left"><a href="talks/20201103/5_Li.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Andrew Hartley</td>
<td align="left">PPDI</td>
<td align="left">Impact of Covid-19 on studies in Neuroscience</td>
<td align="left"><a href="talks/20201103/6_Hartley.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Joel Raffel and Khadija Rantell</td>
<td align="left">MHRA, UK</td>
<td align="left">Regulatory aspects of the estimand framework: Clinical and statistical perspectives</td>
<td align="left"><a href="talks/20201103/7_Raffel.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Anja Schiel</td>
<td align="left">Chair Scientific Advice Working Party, EMA</td>
<td align="left">Panel discussion including all speakers</td>
<td align="left"><a href="talks/20201103/8_Schiel.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-webinar-rcts-meeting-causal-inference-principal-stratum-strategy-and-beyond" class="section level1 unnumbered">
<h1 class="unnumbered">07.09.2020: BBS Webinar RCTs meeting causal inference: principal stratum strategy and beyond</h1>
<p><a href="talks/20200907/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/BBS_RCTs+meeting+causal+inferenceA+principal+stratum+strategy+and+beyond-20200907+1200-1_188928352/0_gqww13rq">Recording</a></p>
<table>
<colgroup>
<col width="6%" />
<col width="33%" />
<col width="45%" />
<col width="14%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kaspar Rufibach</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome and scene setting</td>
<td align="left"><a href="talks/20200907/1_Rufibach.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Vanessa Didelez</td>
<td align="left">Keynote speaker, Leibniz Institute for Prevention Research and Epidemiology, BIPS, Bremen</td>
<td align="left">Time-Varying Treatments in Observational Studies: Lessons for Clinical Trials</td>
<td align="left"><a href="talks/20200907/2_Didelez.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Jack Bowden</td>
<td align="left">University of Exeter</td>
<td align="left">Connecting Instrumental Variable methods for causal inference to the Estimand Framework</td>
<td align="left"><a href="talks/20200907/3_Bowden.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Kelly van Lancker</td>
<td align="left">Ghent University</td>
<td align="left">Efficient, doubly robust estimation of the effect of dose switching for switchers in a randomised clinical trial</td>
<td align="left"><a href="talks/20200907/4_vanLancker.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Björn Bornkamp</td>
<td align="left">Novartis, Basel</td>
<td align="left">Principal Stratum Strategy: Potential Role in Drug Development</td>
<td align="left"><a href="talks/20200907/5_Bornkamp.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Dominik Heinzmann</td>
<td align="left">Roche, Basel</td>
<td align="left">Principal stratum strategy to investigate anti-drug antibody impact on cancer immunotherapy outcome</td>
<td align="left"><a href="talks/20200907/6_Heinzmann.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Aiesha Zia</td>
<td align="left">Novartis, Basel</td>
<td align="left">Exploring estimation approaches for principal stratum estimands in Phase III randomized trials in CAR-T anti-cancer therapy</td>
<td align="left"><a href="talks/20200907/7_Zia.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Fabrizia Mealli</td>
<td align="left">University of Florence</td>
<td align="left">The ICH E9 addendum from an academic causal inference perspective and feedback on the previous talks</td>
<td align="left"><a href="talks/20200907/8_Mealli.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Giusi Moffa</td>
<td align="left">University of Basel</td>
<td align="left">Next webinars and closure</td>
<td align="left"><a href="talks/20200907/9_Moffa.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">All</td>
<td align="left"></td>
<td align="left">Question and Answers</td>
<td align="left"><a href="talks/20200907/10_QandA.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbsefspi-webinar-on-hta" class="section level1 unnumbered">
<h1 class="unnumbered">30.06.2020: BBS/EFSPI Webinar on HTA</h1>
<p><a href="talks/20200630/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/1_jtcj5hqp">Recording</a></p>
<table>
<colgroup>
<col width="9%" />
<col width="20%" />
<col width="52%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Chrissie Fletcher</td>
<td align="left">GSK, UK</td>
<td align="left">Celebrating 10 Years HTA SIG</td>
<td align="left"><a href="talks/20200630/1_Fletcher.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Christoph Schürmann</td>
<td align="left">IQWiG, Germany</td>
<td align="left">Health-related quality of life endpoints in benefit assessments: Demands and challenges as seen by IQWiG in Germany</td>
<td align="left"><a href="talks/20200630/2_Schuermann.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Lara Wolfson</td>
<td align="left">Merck, USA</td>
<td align="left">Issues related to transparency with HTA dossiers</td>
<td align="left"><a href="talks/20200630/3_Wolfson.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mark Nuijten</td>
<td align="left">A2M and Univ. of Maastricht, NL &amp; ITU, Turkey</td>
<td align="left">An innovative pricing model to assess the price of expensive drugs with an orphan indication</td>
<td align="left"><a href="talks/20200630/4_Nuijten.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Fred Sorenson</td>
<td align="left">Xcenda</td>
<td align="left">Introduction to moderated panel discussion</td>
<td align="left"><a href="talks/20200630/5_Sorensen.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="joint-efspi-bbs-webinar-estimands-addendum-is-final-anything-new-for-oncology" class="section level1 unnumbered">
<h1 class="unnumbered">29.06.2020: Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology?</h1>
<p><a href="talks/20200629/agenda.pdf">Agenda</a></p>
<p><a href="https://streamingmedia.roche.com/media/Joint+EFSPI+++BBS+SeminarA+Estimands+addendum+is+finalA+Anything+new+for+oncologyF/1_3wavzkyv">Recording</a></p>
<table>
<colgroup>
<col width="19%" />
<col width="23%" />
<col width="32%" />
<col width="25%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kaspar Rufibach</td>
<td align="left">Roche, Basel</td>
<td align="left">Welcome and scene setting</td>
<td align="left"><a href="talks/20200629/1_Rufibach.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Anja Schiel</td>
<td align="left">Chair Scientific Advice Working Party, EMA</td>
<td align="left">Experience with the estimand framework in oncology</td>
<td align="left"><a href="talks/20200629/2_Schiel.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Renaud Capdeville</td>
<td align="left">Novartis, Basel</td>
<td align="left">Challenges and open questions in hematology: RATIFY</td>
<td align="left"><a href="talks/20200629/3_Capdeville.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Tina Nielsen</td>
<td align="left">Roche, Basel</td>
<td align="left">Challenges and open questions in hematology: GALLIUM</td>
<td align="left"><a href="talks/20200629/4_Nielsen.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Hannes Buchner and Ingolf Griebsch</td>
<td align="left">Staburo and Boehringer-Ingelheim</td>
<td align="left">Treatment switching: challenges, estimands, and estimators</td>
<td align="left"><a href="talks/20200629/5_Griebsch_Buchner.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Stefan Englert</td>
<td align="left">Abbvie</td>
<td align="left">Commentary on previous talks taking COVID-19 into account</td>
<td align="left"><a href="talks/20200629/6_Englert.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">All</td>
<td align="left"></td>
<td align="left">Question and Answers</td>
<td align="left"><a href="talks/20200629/7_QandA.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-webinar-aspects-of-covid-19-pandemic" class="section level1 unnumbered">
<h1 class="unnumbered">03.06.2020: BBS Webinar: Aspects of COVID-19 pandemic</h1>
<p><a href="talks/20200603/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="14%" />
<col width="51%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Jean Lang</td>
<td align="left">Sanofi Pasteur</td>
<td align="left">Overview on SARS-CoV2 and Challenges for COVID-19 Vaccine Development at Pandemic Speed</td>
<td align="left"><a href="talks/20200603/1_Lang.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Christian Althaus</td>
<td align="left">ISPM, University of Bern</td>
<td align="left">Early transmission, pandemic spread and severity of COVID-19</td>
<td align="left"><a href="talks/20200603/2_Althaus.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Karin Meiser</td>
<td align="left">Novartis, Basel</td>
<td align="left">Specific aspects of a clinical trial targeting Covid-19</td>
<td align="left"><a href="talks/20200603/3_Meiser.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Jenny Devenport</td>
<td align="left">Roche, Basel</td>
<td align="left">The influence of investigator initiated studies in the COVID-19 pandemic</td>
<td align="left"><a href="talks/20200603/4_Devenport.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-virtual-seminar-impact-of-covid-19-on-clinical-trials" class="section level1 unnumbered">
<h1 class="unnumbered">06.05.2020: BBS Virtual Seminar: Impact of COVID-19 on clinical trials</h1>
<p><a href="talks/20200506/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="10%" />
<col width="53%" />
<col width="25%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Frank Petavy</td>
<td align="left">EMA</td>
<td align="left">EMA perspective and guidance on COVID-19</td>
<td align="left"><a href="talks/20200506/1_Petavy.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Natalie Dimier</td>
<td align="left">Roche, Welwyn</td>
<td align="left">Industry perspective on COVID-19 (1/3)</td>
<td align="left"><a href="talks/20200506/2_Dimier.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Mouna Akacha</td>
<td align="left">Novartis, Basel</td>
<td align="left">Industry perspective on COVID-19 (2/3)</td>
<td align="left"><a href="talks/20200506/3_Akacha.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Cristina Sotto</td>
<td align="left">J&amp;J</td>
<td align="left">Industry perspective on COVID-19 (3/3)</td>
<td align="left"><a href="talks/20200506/4_Sotto.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Marcel Wolbers</td>
<td align="left">Roche, Basel</td>
<td align="left">Short Overview of Pharmaceutical Industry COVID-19 Biostatistics Working Group</td>
<td align="left"><a href="talks/20200506/5_Wolbers.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Evgeny Degtyarev</td>
<td align="left">Novartis, Basel</td>
<td align="left">Short overview on COVID-19 from the Cross-Industry Oncology Estimands Working Group</td>
<td align="left"><a href="talks/20200506/6_Degtyarev.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-network-meta-analysis-methods-and-applications" class="section level1 unnumbered">
<h1 class="unnumbered">04.02.2020: BBS Seminar: Network meta-analysis: methods and applications</h1>
<p><a href="talks/20200204/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="9%" />
<col width="6%" />
<col width="62%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Sylwia Bujkiewicz</td>
<td align="left"></td>
<td align="left"> Bivariate network meta-analysis for surrogate endpoint evaluation</td>
<td align="left"><a href="talks/20200204/1_Bujkiewicz.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Gerta Rücker</td>
<td align="left"></td>
<td align="left"> Component network meta-analysis compared to a matching method in a disconnected network: a case study</td>
<td align="left"><a href="talks/20200204/2_Ruecker.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Georgia Salanti</td>
<td align="left"></td>
<td align="left"> CINeMA: a framework and web application to evaluate the confidence in network meta-analysis results</td>
<td align="left"><a href="talks/20200204/3_Salanti.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mark Pletscher</td>
<td align="left"></td>
<td align="left"> Network meta-analysis of treatments for previously untreated metastatic PD-L1-positive triple-negative breast cancer</td>
<td align="left"><a href="talks/20200204/4_Pletscher.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Bartosz Jenner</td>
<td align="left"></td>
<td align="left">An experience with indirect treatment comparisons using MAIC methods in a rare disease</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Marius Thomas</td>
<td align="left"></td>
<td align="left"> A network meta-analysis to compare efficacy of treatment options for relapsing-remitting multiple sclerosis</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-predictive-modelling-machine-learning-and-causality" class="section level1 unnumbered">
<h1 class="unnumbered">01.11.2019: BBS Seminar: Predictive modelling, machine learning and causality</h1>
<p><a href="talks/20191101/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<p><a href="20191101_summary.html">Summary of the event</a></p>
<table>
<colgroup>
<col width="8%" />
<col width="5%" />
<col width="54%" />
<col width="32%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Ewout Steyerberg</td>
<td align="left"></td>
<td align="left"> Clinical prediction models in the age of artificial intelligence and big data</td>
<td align="left"><a href="talks/20191101/1_Steyerberg.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Willi Sauerbrei</td>
<td align="left"></td>
<td align="left"> The EQUATOR networkand guidelines for prediction models</td>
<td align="left"><a href="talks/20191101/2_Sauerbrei.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Torsten Hothorn</td>
<td align="left"></td>
<td align="left"> Score-based transformation learning</td>
<td align="left"><a href="talks/20191101/3_Hothorn.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Peter Bühlmann</td>
<td align="left"></td>
<td align="left"> Causal regularization for distributional robustness and replicability</td>
<td align="left"><a href="talks/20191101/4_Buehlmann.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Giusi Moffa</td>
<td align="left"></td>
<td align="left"> Predicting putative intervention effects after causal structure learning from survey data</td>
<td align="left"><a href="https://annlia.github.io/jPublica/BBS_201911/psychoDAGs201911.html">link</a></td>
</tr>
<tr class="even">
<td align="left">Andrew Shattock</td>
<td align="left"></td>
<td align="left">Using machine learning and disease models to evaluate target product profiles of novel interventions (No slide deck available)</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Federico Mattiello</td>
<td align="left"></td>
<td align="left"> Identifying high-risk patients in Non-Hodgkin lymphoma (and trying to get insights into the disease biology)</td>
<td align="left"><a href="talks/20191101/7_Mattiello.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mark Baillie</td>
<td align="left"></td>
<td align="left"> Novartis benchmarking initiative: making sense of AI</td>
<td align="left"><a href="talks/20191101/8_Baillie.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Chris Harbron</td>
<td align="left"></td>
<td align="left"> Experiences from running internal prediction challenges within a pharmaceutical company</td>
<td align="left"><a href="talks/20191101/9_Harbron.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbsbes-seminar-causal-inference-in-drug-development-why-when-how" class="section level1 unnumbered">
<h1 class="unnumbered">21.08.2019: BBS/BES Seminar: Causal inference in drug development: why, when, how?</h1>
<p><a href="talks/20190821/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="6%" />
<col width="64%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Miguel Hernan</td>
<td align="left"></td>
<td align="left"> Beyond intention-to-treat. Causal inference guidelines for causal inference</td>
<td align="left"><a href="talks/20190821/1_Hernan.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Christine Fletcher</td>
<td align="left"></td>
<td align="left"> The Final ICH E9(R1) E9 addendum</td>
<td align="left"><a href="talks/20190821/2_Fletcher.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Frank Pe´tavy</td>
<td align="left"></td>
<td align="left"> A regulator’s perspective</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Valentine Jehl</td>
<td align="left"></td>
<td align="left">Adverse reactions confounded by prior medication: (how) can causal inference solve the problem?</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Thibaut Sanglier</td>
<td align="left"></td>
<td align="left">Treatment sequencing and effectiveness: challenges and considerations</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Nikolaos Sfikas</td>
<td align="left"></td>
<td align="left">Principal stratification techniques in the context of regulatory decision making</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Jack Bowden</td>
<td align="left"></td>
<td align="left"> Implementing the Principal Stratum estimand strategy using Instrumental Variable methods: An emulation of the CANTOS trial</td>
<td align="left"><a href="talks/20190821/7_Bowden.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbsefspi-seminar-precision-medicine-in-drug-development" class="section level1 unnumbered">
<h1 class="unnumbered">04.06.2019: BBS/EFSPI Seminar: Precision medicine in drug development</h1>
<p><a href="talks/20190604/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="8%" />
<col width="5%" />
<col width="66%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Niko Beerenwinkel</td>
<td align="left"></td>
<td align="left">Bioinformatics for precision oncology</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Stephen Senn</td>
<td align="left"></td>
<td align="left"> Precision medicine: The honeymoon is over. It’s high time for tough love</td>
<td align="left"><a href="talks/20190604/2_Senn.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Tomasz Burzykowski</td>
<td align="left"></td>
<td align="left"> Generalized pairwise comparisons for precision medicine</td>
<td align="left"><a href="talks/20190604/3_Burzykowski.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Adam Heathfield</td>
<td align="left"></td>
<td align="left"> Valuation of Regenerative Medicine/Advance Therapeutics (RM/ATs): Challenges and opportunities for creating a better framework</td>
<td align="left"><a href="talks/20190604/4_Heathfield.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Jack Kuipers</td>
<td align="left"></td>
<td align="left"> Mutational interactions define novel cancer subgroups: can they inform precision oncology?</td>
<td align="left"><a href="talks/20190604/5_Kuipers.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mario Ouwens</td>
<td align="left"></td>
<td align="left"> Difficulties with network meta-analysis when starting to use PDL1 thresholds</td>
<td align="left"><a href="talks/20190604/6_Ouwens.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Georgina Bermann</td>
<td align="left"></td>
<td align="left"> Cardiovascular medicine: approaches to the use of early biomarker response to identify a patient subgroup with enhanced therapeutic benefit</td>
<td align="left"><a href="talks/20190604/7_Bermann.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Laurent Essioux</td>
<td align="left"></td>
<td align="left"> Examples of personalized Healthcare at Roche: statistical perspectives</td>
<td align="left"><a href="talks/20190604/8_Essioux.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar-synthetic-controls---what-do-we-need-and-how-far-can-we-go" class="section level1 unnumbered">
<h1 class="unnumbered">10.05.2019: BBS Spring Seminar: Synthetic controls - what do we need and how far can we go?</h1>
<p><a href="talks/20190510/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="17%" />
<col width="5%" />
<col width="57%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Tom Brookland</td>
<td align="left"></td>
<td align="left"> RWD/RWE Global Regulatory Overview</td>
<td align="left"><a href="talks/20190510/1_Brookland.zip">link</a></td>
</tr>
<tr class="even">
<td align="left">Kaspar Rufibach and Hans Ulrich Burger</td>
<td align="left"></td>
<td align="left"> External controls in drug development</td>
<td align="left"><a href="talks/20190510/2_Rufibach_Burger.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Somnath Sarkar</td>
<td align="left"></td>
<td align="left"> Considerations for Developing External Control Arm from Real-World Data</td>
<td align="left"><a href="talks/20190510/3_Sarkar.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Laurence Colin and Yue Li</td>
<td align="left"></td>
<td align="left"> Making better use of early phase safety data</td>
<td align="left"><a href="talks/20190510/4_Colin_Li.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Cornelia Dunger-Baldauf</td>
<td align="left"></td>
<td align="left"> For the sake of the patient – reducing placebo exposure by using historical controls</td>
<td align="left"><a href="talks/20190510/5_DungerBaldauf.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Gonzalo Duran-Pacheco</td>
<td align="left"></td>
<td align="left"> Electronic Health Records used to derive Control Arms for Single-Arm oncology trials: Proof of concept using RCT’s in lung cancer</td>
<td align="left"><a href="talks/20190510/6_Duran_Pacheco.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Chris Harbron</td>
<td align="left"></td>
<td align="left"> A Decision Making Framework For Utilising External Control Arms</td>
<td align="left"><a href="talks/20190510/7_Harbron.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Meinhard Kieser</td>
<td align="left"></td>
<td align="left"> Synthetic controls – what do we need and how far can we go? Rejoinder</td>
<td align="left"><a href="talks/20190510/8_Kieser.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Norbert Benda</td>
<td align="left"></td>
<td align="left"> Synthetic controls – what do we need and how far can we go? Rejoinder</td>
<td align="left"><a href="talks/20190510/9_Benda.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Kit Roes</td>
<td align="left"></td>
<td align="left"> Synthetic controls – what do we need and how far can we go? Rejoinder</td>
<td align="left"><a href="talks/20190510/10_Roes.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Jan Müller-Berghaus</td>
<td align="left"></td>
<td align="left"> Synthetic controls – what do we need and how far can we go? Rejoinder</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Anja Schiel</td>
<td align="left"></td>
<td align="left"> Synthetic controls – what do we need and how far can we go? Rejoinder</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbsefspi-seminar-small-populations-and-level-of-evidence" class="section level1 unnumbered">
<h1 class="unnumbered">27.06.2018: BBS/EFSPI Seminar: Small populations and level of evidence</h1>
<p><a href="talks/20180627/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="14%" />
<col width="5%" />
<col width="62%" />
<col width="17%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Fred Sorensen</td>
<td align="left"></td>
<td align="left">European Statistical Meeting on Small populations and level of evidence</td>
<td align="left"><a href="talks/20180627/1_Sorensen.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Daniel O’Connor</td>
<td align="left"></td>
<td align="left"> Rare diseases and orphan drugs: A Regulator’s (clinical)Perspectives</td>
<td align="left"><a href="talks/20180627/2_OConnor.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Stephen Senn</td>
<td align="left"></td>
<td align="left"> In search of the lost loss function</td>
<td align="left"><a href="talks/20180627/3_Senn.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Henriette Thole</td>
<td align="left"></td>
<td align="left"> The potential and challenges of registry use when generating evidence in small populations</td>
<td align="left"><a href="talks/20180627/4_Thole.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Anja Schiel</td>
<td align="left"></td>
<td align="left"> Rare diseases and orphan drugs:The HTA perspective</td>
<td align="left"><a href="talks/20180627/5_Schiel.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Adele Morganti</td>
<td align="left"></td>
<td align="left"> Borrowing external controls for an event-driven pediatric trial in PAH: a case study</td>
<td align="left"><a href="talks/20180627/6_Morganti.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Andreas Kaiser</td>
<td align="left"></td>
<td align="left"> Bayesian analysis for small sample size trials using informative priors derived from historical data</td>
<td align="left"><a href="talks/20180627/7_Kaiser.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Elina Asikanius</td>
<td align="left"></td>
<td align="left"> Using a non-interventional study to strengthen the evidence collected in a Phase III program: a Hemophilia A case Study</td>
<td align="left"><a href="talks/20180627/8_Asikanius.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Hans Hockey and Kristian Brock</td>
<td align="left"></td>
<td align="left"> Hockey sticks and broken sticks – a design for a single-treatment double-blind randomized clinical trial suitable for chronic diseases</td>
<td align="left"><a href="talks/20180627/9_Hockey.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-rcts-personalized-medicine-and-surrogacy" class="section level1 unnumbered">
<h1 class="unnumbered">26.06.2018: BBS Seminar: RCTs, personalized medicine, and surrogacy</h1>
<p><a href="talks/20180626/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="12%" />
<col width="7%" />
<col width="54%" />
<col width="25%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Tomasz Burzykowski</td>
<td align="left"></td>
<td align="left">Evaluation of Time-to-event Surrogate Endpoints Using Accelerated Failure-time Models</td>
<td align="left"><a href="talks/20180626/1_Burzykowski.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Everardo D. Saad</td>
<td align="left"></td>
<td align="left">Precision Medicine Needs Randomized Trials</td>
<td align="left"><a href="talks/20180626/2_Saad.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Marc Buyse</td>
<td align="left"></td>
<td align="left">A statistical approach for personalized medicine and benefit / risk assessment</td>
<td align="left"><a href="talks/20180626/3_Buyse.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar-new-developments-in-hta-adaptive-designs-and-multiplicity-in-remembrance-of-willi-maurer" class="section level1 unnumbered">
<h1 class="unnumbered">17.04.2018: BBS Spring Seminar: New developments in HTA, adaptive designs and multiplicity – in remembrance of Willi Maurer</h1>
<p><a href="talks/20180417/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="10%" />
<col width="6%" />
<col width="63%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Jason Wang</td>
<td align="left"></td>
<td align="left">Sense and sensibility of estimands for health technology assessment (HTA)</td>
<td align="left"><a href="talks/20180417/1_Wang.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Christoph Gerlinger</td>
<td align="left"></td>
<td align="left">EQ-5D-5L Utility Index for different countries</td>
<td align="left"><a href="talks/20180417/2_Gerliner.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Susan Edwards</td>
<td align="left"></td>
<td align="left">Whose perspective? Implications on cost-effectiveness modelling of differences between country value sets (a case study)</td>
<td align="left"><a href="talks/20180417/3_Edwards.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Carsten Schwenke</td>
<td align="left"></td>
<td align="left">Real World Evidence and HTA – Experiences with IQWiG</td>
<td align="left"><a href="talks/20180417/4_Schwenke.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Tim Friede</td>
<td align="left"></td>
<td align="left">HTA AND SAFETY Some results of the ATF / APF Project Group</td>
<td align="left"><a href="talks/20180417/5_Friede.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-competing-risks-and-multi-state-models" class="section level1 unnumbered">
<h1 class="unnumbered">20.03.2018: BBS Seminar: Competing Risks and Multi-State Models</h1>
<p><a href="talks/20180320/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="17%" />
<col width="6%" />
<col width="52%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Claudia Schmoor</td>
<td align="left"></td>
<td align="left"> Competing risks with applications to oncology</td>
<td align="left"><a href="talks/20180320/1_Schmoor.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Jan Beyersmann</td>
<td align="left"></td>
<td align="left"> Analysis of co-time-to-event outcomes in randomized clinical trials</td>
<td align="left"><a href="talks/20180320/2_Beyersmann.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Ekkehard Glimm and Lillian Yau</td>
<td align="left"></td>
<td align="left"> A discrete semi-Markov model for the effect of need-based treatments on the disease states</td>
<td align="left"><a href="talks/20180320/3_Glimm.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-future-of-biomedical-research-are-we-ready" class="section level1 unnumbered">
<h1 class="unnumbered">14.11.2017: BBS Seminar: Future of Biomedical Research: Are we ready?</h1>
<p><a href="talks/20171114/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="8%" />
<col width="26%" />
<col width="52%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Damian Roqueiro</td>
<td align="left">Machine Learning and Computational Biology Lab ETH Zurich</td>
<td align="left">Applications of Machine Learning and Deep Learning</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Jonas Dorn</td>
<td align="left">Novartis, Basel</td>
<td align="left">Machine learning when the ground truth isn’t truth and privacy is a problem – case study from the Assess MS project</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Hans Ulrich Burger</td>
<td align="left">Roche, Basel</td>
<td align="left">Big clinical data: What should biometrician do with it?</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-emerging-topics-for-statistical-methodology-in-drug-development-estimands-and-advanced-analytics" class="section level1 unnumbered">
<h1 class="unnumbered">11.09.2017: BBS Seminar Emerging topics for statistical methodology in drug development: Estimands and advanced analytics</h1>
<p><a href="talks/20170911/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="9%" />
<col width="33%" />
<col width="46%" />
<col width="10%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Stephen Ruberg</td>
<td align="left">Eli Lilly</td>
<td align="left">The patient perspective – the estimands they want</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Stef van Buuren,</td>
<td align="left">Netherlands Organisation for Applied Scientific Research and University of Utrecht</td>
<td align="left">Individual causal effect: What is it? Why we need it? How to estimate it?</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Baldur Magnusson</td>
<td align="left">Novartis, Basel</td>
<td align="left">Using principal stratification to disentangle post-randomization outcomes in a randomized controlled phase 3 study</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Teresa Barata</td>
<td align="left">Roche, Basel</td>
<td align="left">Estimands in early Parkinson disease</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Stephen Ruberg</td>
<td align="left">Eli Lilly</td>
<td align="left">Making what’s advanced today routine tomorrow</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Jouni Kerman</td>
<td align="left">Google</td>
<td align="left">Causal Measurement using Geo Experiments in a Time-Based Regression Framework</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Cornelia Dunger-Baldauf</td>
<td align="left">Novartis, Basel</td>
<td align="left">A Smartphone-Based Study Capturing Longitudinal Vision Test Data, Movement Scores and User-reported Outcomes</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Fabio Pellegrini</td>
<td align="left">Biogen</td>
<td align="left">Individualized medicine based on a treatment response continuous score</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-innovative-model-based-dose-escalation-designs-what-next" class="section level1 unnumbered">
<h1 class="unnumbered">26.06.2017: BBS Seminar Innovative model-based dose escalation designs: what next?</h1>
<p><a href="talks/20170626/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="14%" />
<col width="8%" />
<col width="50%" />
<col width="26%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Daniel Sabanés Bové</td>
<td align="left"></td>
<td align="left"> Model-based D/E designs: Current status and next steps</td>
<td align="left"><a href="talks/20170626/1_Sabanes.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Daniel Lorand</td>
<td align="left"></td>
<td align="left"> Tailoring dose escalation designs to early clinical development goals</td>
<td align="left"><a href="talks/20170626/2_Lorand.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Andreas Krause</td>
<td align="left"></td>
<td align="left"> Guiding dose escalation studies in Phase 1 with unblinded modeling</td>
<td align="left"><a href="talks/20170626/3_Krause.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-psi-1-day-scientific-meeting-empower-the-immune-system-to-fight-cancer" class="section level1 unnumbered">
<h1 class="unnumbered">15.06.2017: BBS / PSI 1-Day Scientific Meeting: Empower the immune system to fight cancer</h1>
<p><a href="talks/20170615/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="6%" />
<col width="62%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Jorge Martinalbo</td>
<td align="left"></td>
<td align="left"> Realising the potential of cancer immunotherapy</td>
<td align="left"><a href="talks/20170615/1_Martinalbo.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Andrew Stone</td>
<td align="left"></td>
<td align="left">Statistical issues in the development of cancer immunotherapy</td>
<td align="left"><a href="talks/20170615/2_Stone.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Daniel Sabanés Bové</td>
<td align="left"></td>
<td align="left">Bayesian Learning in Early Phase Cancer Immunotherapy: A Case Study</td>
<td align="left"><a href="talks/20170615/3_Sabanes.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Matt Whiley</td>
<td align="left"></td>
<td align="left">An adaptive phase II basket trial design</td>
<td align="left"><a href="talks/20170615/4_Whiley.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Dominik Heinzmann</td>
<td align="left"></td>
<td align="left">Statistical, clinical and ethical considerations when minimizing</td>
<td align="left"><a href="talks/20170615/5_Heinzmann.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Claude Berge</td>
<td align="left"></td>
<td align="left">Statistical Challenges in Immunotherapy: Non Proportional Hazard Model</td>
<td align="left"><a href="talks/20170615/6_Berge.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Sergio Fracchia</td>
<td align="left"></td>
<td align="left">Challenges in development and approval: the case of cell based therapeutics</td>
<td align="left"><a href="talks/20170615/7_Fracchia.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Fred Sorenson</td>
<td align="left"></td>
<td align="left">Cancer Immunotherapy from the Health Technology Assessment (HTA) and Payer Perspectives</td>
<td align="left"><a href="talks/20170615/8_Sorensen.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Nicholas Latimer</td>
<td align="left"></td>
<td align="left">Estimating survival benefit for health technology assessment: New challenges presented by immuno-oncology treatments?</td>
<td align="left"><a href="talks/20170615/9_Latimer.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar-the-use-of-external-data-for-decision-making" class="section level1 unnumbered">
<h1 class="unnumbered">05.05.2017: BBS Spring Seminar The use of external data for decision making</h1>
<p><a href="talks/20170505/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="6%" />
<col width="61%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">David Evans</td>
<td align="left"></td>
<td align="left">Reality and Real-World Data</td>
<td align="left"><a href="talks/20170505/1_Evans.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Ralf Bender</td>
<td align="left"></td>
<td align="left">Use of registries and observational data in the benefit assessment of medical interventions</td>
<td align="left"><a href="talks/20170505/2_Bender.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Frank Bretz</td>
<td align="left"></td>
<td align="left">Threshold-crossing: A Useful Way to Establish the Counterfactual in Clinical Trials?</td>
<td align="left"><a href="talks/20170505/3_Bretz.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">David Dejardin</td>
<td align="left"></td>
<td align="left">Dynamic borrowing of historical data: Performance and comparison of existing methods based on a case study</td>
<td align="left"><a href="talks/20170505/4_Dejardin.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Eva-Maria Didden</td>
<td align="left"></td>
<td align="left">GetReal: 3 Years on!</td>
<td align="left"><a href="talks/20170505/5_Didden.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Tim Friede</td>
<td align="left"></td>
<td align="left">The Use of External Data for Decision Making</td>
<td align="left"><a href="talks/20170505/6_Friede.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-biomarker-analyses" class="section level1 unnumbered">
<h1 class="unnumbered">13.03.2017: BBS Seminar: Biomarker analyses</h1>
<p><a href="talks/20170313/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="14%" />
<col width="54%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Werner Vach</td>
<td align="left">Universitätsspital Basel</td>
<td align="left">Statistical perspectives on umbrella trials</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Kaspar Rufibach</td>
<td align="left">Roche, Basel</td>
<td align="left">Comparison of clinical development plans for a confirmatory trial with subpopulation selection</td>
<td align="left"><a href="talks/20170313/2_Rufibach.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-safety-monitoring-during-the-life-cycle-of-a-drug" class="section level1 unnumbered">
<h1 class="unnumbered">29.11.2016: BBS Seminar: Safety monitoring during the life cycle of a drug</h1>
<p><a href="talks/20161129/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="14%" />
<col width="9%" />
<col width="45%" />
<col width="30%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Conny Berlin</td>
<td align="left"></td>
<td align="left">Safety monitoring during the life cycle of a drug</td>
<td align="left"><a href="talks/20161129/1_Berlin.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Yusuf Tanrikulu</td>
<td align="left"></td>
<td align="left">Signal Detection – Quantitative Analysis of Safety Data</td>
<td align="left"><a href="talks/20161129/2_Tanrikulu.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Pritibha Singh</td>
<td align="left"></td>
<td align="left">Adverse Drug Reaction (ADR) screening in clinical trials</td>
<td align="left"><a href="talks/20161129/3_Singh.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Gianmario Candore</td>
<td align="left"></td>
<td align="left">Screening for adverse reactions in EudraVigilance</td>
<td align="left"><a href="talks/20161129/4_Candore.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Soheila Aghlmandi</td>
<td align="left"></td>
<td align="left">Choice of priors in rare events meta-analysis</td>
<td align="left"><a href="talks/20161129/5_Aghlmandi.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-synthesis-of-evidence-observational-studies-and-meta-analysis" class="section level1 unnumbered">
<h1 class="unnumbered">14.11.2016: BBS Seminar: Synthesis of Evidence: Observational studies and Meta-analysis</h1>
<p><a href="talks/20161114/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="10%" />
<col width="8%" />
<col width="66%" />
<col width="14%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kay Brodersen</td>
<td align="left">Google, Zurich</td>
<td align="left">Inferring causal effects in the absence of an experiment using CausalImpact</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">David Rasmussen</td>
<td align="left">ETH Zurich</td>
<td align="left">Using HIV phylogenetics to quantify how human mobility impacts antiretroviral-based prevention strategies</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Almut Mecke</td>
<td align="left">Roche, Basel</td>
<td align="left">Different endpoints for meta-analyses of safety information</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Friedhelm Leverkus</td>
<td align="left">Pfizer Germany</td>
<td align="left">Meta-analysis in support of the German Benefit Assessment for Reimbursement (Arzneimittelmarkt-Neuordnungsgesetz – AMNOG</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-missing-data-and-graphical-models" class="section level1 unnumbered">
<h1 class="unnumbered">17.10.2016: BBS Seminar: Missing Data and Graphical Models</h1>
<p><a href="talks/20161017/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="8%" />
<col width="11%" />
<col width="60%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Jane Hutton</td>
<td align="left">Uni Warwick</td>
<td align="left">Missing data and how to see biased results using Chain Event Graphs</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Giusi Moffa</td>
<td align="left">Novartis, Basel</td>
<td align="left">Cancer profiling and subtype discovery with Bayesian inference for acyclic digraphs</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Markus Elze</td>
<td align="left">Roche, Basel</td>
<td align="left">Propensity scores methods and covariate adjustment in practice</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="psibbs-one-day-meeting-time-to-event-and-recurrent-event-endpoints" class="section level1 unnumbered">
<h1 class="unnumbered">14.09.2016: PSI/BBS One Day Meeting: Time-to-Event and Recurrent Event Endpoints</h1>
<p><a href="talks/20160914/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="12%" />
<col width="61%" />
<col width="16%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Lilla Di Scala</td>
<td align="left">Actelion, Basel</td>
<td align="left">Informative censoring in a rare disease: a regulatory experience in PAH</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Dominic Magirr</td>
<td align="left">AstraZeneca</td>
<td align="left">Unblinded sample-size reassessment in time-to-event clinical trials</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Tobias Bluhmki</td>
<td align="left">Universität Ulm</td>
<td align="left">Analyzing non-monotonous time-to-event outcome probabilities in randomized clinical trials</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Jennifer Rogers</td>
<td align="left">University of Oxford</td>
<td align="left">The analysis of recurrent events: A summary of methodology</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Mouna Akacha</td>
<td align="left">Novartis, Basel</td>
<td align="left">Recurrent event data endpoints in chronic heart failure studies: What is the estimand of interest?</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Ekkehard Glimm</td>
<td align="left">Novartis, Basel</td>
<td align="left">Sample size and interim analysis considerations for recurrent event data analyses</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-adaptive-designs" class="section level1 unnumbered">
<h1 class="unnumbered">04.05.2016: BBS Seminar: Adaptive Designs</h1>
<p><a href="talks/20160504/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="7%" />
<col width="55%" />
<col width="24%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Franz König</td>
<td align="left"></td>
<td align="left">Regulatory and methodological issues in adaptive designs for confirmatory trials</td>
<td align="left"><a href="talks/20160504/1_Koenig.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Peter Bauer</td>
<td align="left"></td>
<td align="left">DMC membership experience</td>
<td align="left"><a href="talks/20160504/2_Bauer.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">David Lawrence</td>
<td align="left"></td>
<td align="left">Using a DMC for dose selection in a phase IIb/III adaptive design: the INHANCE study</td>
<td align="left"><a href="talks/20160504/3_Lawrence.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Alexander Strasak</td>
<td align="left"></td>
<td align="left">Adaptive seamless phase II/III study in gastric cancer</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar" class="section level1 unnumbered">
<h1 class="unnumbered">28.04.2016: BBS Spring Seminar</h1>
<p><a href="talks/20160428/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="5%" />
<col width="60%" />
<col width="21%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kaspar Rufibach</td>
<td align="left"></td>
<td align="left">Event projection: quantify uncertainty and manage expectations of broader teams</td>
<td align="left"><a href="talks/20160428/1_Rufibach.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Beat Neuenschwander</td>
<td align="left"></td>
<td align="left">Predicting milestone events for time-to-event trials</td>
<td align="left"><a href="talks/20160428/2_Neuenschwander.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Melissa Penny</td>
<td align="left"></td>
<td align="left">Model-based public health impact and cost-effectiveness estimates informing the WHO recommendation on malaria vaccine RTS</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Iain Bennett</td>
<td align="left"></td>
<td align="left">Designing in Treatment Switching (case study review and recommendations)</td>
<td align="left"><a href="talks/20160428/4_Bennett.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Viktoriya Stalbovskaya</td>
<td align="left"></td>
<td align="left">Practical aspects of handling treatment switching in randomized clinical trials</td>
<td align="left"><a href="talks/20160428/5_Stalbovskaya.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Daniel Sabanes</td>
<td align="left"></td>
<td align="left">Cancer immunotherapies: Which efficacy endpoints and statistical analyses to use?</td>
<td align="left"><a href="talks/20160428/6_Sabanes.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Andrew Stone</td>
<td align="left"></td>
<td align="left">Non-Proportional Hazards – So What?</td>
<td align="left"><a href="talks/20160428/7_Stone.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Karine Lheritier</td>
<td align="left"></td>
<td align="left">Complex study design in patients with Hereditary Periodic Fevers</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">David Dejardin</td>
<td align="left"></td>
<td align="left">Bayesian dual endpoint decision making in combination studies</td>
<td align="left"><a href="talks/20160428/9_Dejardin.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Alessandro Matano</td>
<td align="left"></td>
<td align="left">Bayesian approach for Combination Phase I Trials in Oncology</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-disease-and-product-registries" class="section level1 unnumbered">
<h1 class="unnumbered">13.01.2016: BBS Seminar: Disease and Product Registries</h1>
<p><a href="talks/20160113/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="8%" />
<col width="5%" />
<col width="66%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Tim Friede</td>
<td align="left"></td>
<td align="left">Clinical registries: Use and Emerging Best Practices</td>
<td align="left"><a href="talks/20160113/1_Friede.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Eva-Maria Didden</td>
<td align="left"></td>
<td align="left">Learning and Predicting Real-World Treatment Effect based on Randomized Controlled Trials and Registry Data – A Case Study in Rheumatoid Arthritis</td>
<td align="left"><a href="talks/20160113/2_Didden.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Heiner C. Bucher</td>
<td align="left"></td>
<td align="left">Making Better Use of Registry Data in Designing Pragmatic Trials</td>
<td align="left"><a href="talks/20160113/3_Bucher.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Yvonne Geissbühler</td>
<td align="left"></td>
<td align="left">Use of Registries to Collect Pregnancy Data</td>
<td align="left"><a href="talks/20160113/4_Geissbuehler.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Brian Hennessy</td>
<td align="left"></td>
<td align="left">Registries in Rare Diseases / Orphan Drugs along with 2 Case Studies</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Helene Karcher</td>
<td align="left"></td>
<td align="left">Leveraging Real-World Registry Data to Optimize the Design of Phase 3 Studies – a Case Study in Schizophrenia</td>
<td align="left"><a href="talks/20160113/6_Karcher.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-prediction" class="section level1 unnumbered">
<h1 class="unnumbered">27.10.2015: BBS Seminar: Prediction</h1>
<p>No agenda available</p>
<p>No recording available</p>
<table>
<colgroup>
<col width="14%" />
<col width="9%" />
<col width="44%" />
<col width="31%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kaspar Rufibach</td>
<td align="left"></td>
<td align="left">Bayesian Predictive Power: the bathtub problem</td>
<td align="left"><a href="talks/20151027/1_Rufibach.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Evgeny Degtyarev</td>
<td align="left"></td>
<td align="left">Designing Phase 2 to predict success in Phase 3 study</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="joint-bbsefspi-seminar-health-technology-assessment" class="section level1 unnumbered">
<h1 class="unnumbered">23.06.2015: Joint BBS/EFSPI Seminar: Health Technology Assessment</h1>
<p><a href="talks/20150623/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="15%" />
<col width="12%" />
<col width="60%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Chrissie Fletcher &amp; Matthias Egger</td>
<td align="left">Amgen &amp; University of Bern</td>
<td align="left">IMI GetReal Initiative Update</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Panelists</td>
<td align="left"></td>
<td align="left">Expert panel discussion on trends and burning issues, eg. Structured benefit risk and real world evidence; dual EMA-HTA consultation</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Pascale Brasseur</td>
<td align="left">Medtronic</td>
<td align="left">Overview of HTA for medical devices and diagnostics</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Sheryl Warttig</td>
<td align="left">NICE</td>
<td align="left">NICE’s approach to the development of guidance for medical devices and diagnostics</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Karsten Berndt</td>
<td align="left">Roche Diagnostics</td>
<td align="left">EUnetHTA core model applied to Colorectal Cancer screening</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Valéry Risson</td>
<td align="left">Novartis</td>
<td align="left">Uses of Social Media for Outcomes Research – results of a real-world pilot</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Claire Watkins</td>
<td align="left">AstraZeneca</td>
<td align="left">Adjusting overall survival for treatment switch/crossover</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Pierre Ducorneau</td>
<td align="left">Roche, Basel</td>
<td align="left">Using the EUnetHTA HTA core model as a framework for planning, generating and presenting evidence</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Yovanna Castro</td>
<td align="left">Roche, Basel</td>
<td align="left">Predicting long term survival using nonparametric Bayesian methods: the melanoma case</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Nathalie Barbier</td>
<td align="left">Novartis</td>
<td align="left">Reimbursement challenges with new emerging cancer therapies</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Won Lee</td>
<td align="left">Xcenda</td>
<td align="left">The value of Oncology therapies and emerging access hurdles in Canada and the United States</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-bayesian-methods-in-adaptive-dose-finding-trials" class="section level1 unnumbered">
<h1 class="unnumbered">13.04.2015: BBS Seminar: Bayesian Methods in Adaptive Dose-Finding Trials</h1>
<p><a href="talks/20150413/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="6%" />
<col width="61%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Daniel Sabanes Bove</td>
<td align="left"></td>
<td align="left">Bayesian Learning in Oncology: A Case Study</td>
<td align="left"><a href="talks/20150413/1_Sabanes.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Ying Yuan</td>
<td align="left"></td>
<td align="left">Bayesian Data Augmentation Continual Reassessment Method (DA-CRM) for Phase I Trials with Delayed Toxicities</td>
<td align="left"><a href="talks/20150413/2_Yuan.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Daniel Lorand</td>
<td align="left"></td>
<td align="left">Bayesian modelling for combination dose-escalation trial that incorporates pharmacokinetic data</td>
<td align="left"><a href="talks/20150413/3_Lorand.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="joint-bbs-efspi-seminar-data-sharing-in-clinical-development" class="section level1 unnumbered">
<h1 class="unnumbered">13.11.2014: Joint BBS-EFSPI Seminar: Data Sharing in Clinical Development</h1>
<p><a href="talks/20141113/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table style="width:100%;">
<colgroup>
<col width="12%" />
<col width="8%" />
<col width="52%" />
<col width="26%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Sabine Atzor</td>
<td align="left"></td>
<td align="left"> Clinical Trial Data Transparency – Environment &amp; Expectations</td>
<td align="left"><a href="talks/20141113/1_Atzor.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Stefan Driessen</td>
<td align="left"></td>
<td align="left"> EFSPI position on EMA policy on publication of clinical data</td>
<td align="left"><a href="talks/20141113/2_Driessen.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Franz König</td>
<td align="left"></td>
<td align="left"> Big thunder</td>
<td align="left"><a href="talks/20141113/3_Koenig.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Rebecca Sudlow</td>
<td align="left"></td>
<td align="left"> Overview of Data Sharing Initiatives in Industry and Current Experiences</td>
<td align="left"><a href="talks/20141113/4_Sudlow.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Janice Branson</td>
<td align="left"></td>
<td align="left"> Practicalities of accessing and using data – Advice for Researchers</td>
<td align="left"><a href="talks/20141113/5_Branson.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Sally Hollis</td>
<td align="left"></td>
<td align="left"> Considerations for analysis plans for data sharing requests</td>
<td align="left"><a href="talks/20141113/6_Hollis.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Katherine Tucker</td>
<td align="left"></td>
<td align="left"> Principles to maintain patient confidentiality+H211</td>
<td align="left"><a href="talks/20141113/7_Tucker.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Guilliaume Breton</td>
<td align="left"></td>
<td align="left"> Patient Confidentiality Implementation</td>
<td align="left"><a href="talks/20141113/8_Breton.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-meta-analysis-of-clinical-safety-data" class="section level1 unnumbered">
<h1 class="unnumbered">02.10.2014: BBS Seminar: Meta-Analysis of Clinical Safety Data</h1>
<p><a href="talks/20141002/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="7%" />
<col width="60%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Stephen Evans</td>
<td align="left"></td>
<td align="left"> Do meta-analyses of adverse events have adverse effects?</td>
<td align="left"><a href="talks/20141002/1_Evans.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Brenda Crowe</td>
<td align="left"></td>
<td align="left"> Comparison of Bayesian and Frequentist Meta-Analytical Approaches for Analyzing Time to Event Data</td>
<td align="left"><a href="talks/20141002/2_Crowe.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Michael Gaffney</td>
<td align="left"></td>
<td align="left"> Model Selection in Meta-Analysis of Clinical Safety Data – Fixed or Random Study Effect</td>
<td align="left"><a href="talks/20141002/3_Gaffney.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Amy Xia</td>
<td align="left"></td>
<td align="left"> Bayesian Meta-Analysis in Drug Safety Evaluation</td>
<td align="left"><a href="talks/20141002/4_Xia.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Jim Slattery</td>
<td align="left"></td>
<td align="left"> Meta-analysis in EU regulation</td>
<td align="left"><a href="talks/20141002/5_Slattery.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Tarek A. Hammad</td>
<td align="left"></td>
<td align="left"> Sources of Bias in Meta-analysis of RCTs</td>
<td align="left"><a href="talks/20141002/6_Hammad.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Mark Levenson</td>
<td align="left"></td>
<td align="left"> Meta-Analysis for Safety: Context and Examples at US FDA</td>
<td align="left"><a href="talks/20141002/7_Levenson.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-applications-for-statisticians-working-with-real-world-data" class="section level1 unnumbered">
<h1 class="unnumbered">07.05.2014: BBS Seminar: Applications for statisticians working with “Real-World Data”</h1>
<p><a href="talks/20140507/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="20%" />
<col width="9%" />
<col width="49%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Pamela Landsman-Blumberg</td>
<td align="left"></td>
<td align="left">Applications for statisticians working with “Real-World Data”</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Fred Sorensen</td>
<td align="left"></td>
<td align="left"></td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-adaptive-flexible-designs-in-early-development" class="section level1 unnumbered">
<h1 class="unnumbered">04.02.2014: BBS seminar: Adaptive / Flexible Designs in early development</h1>
<p>No agenda available</p>
<p>No recording available</p>
<p>No slides available</p>
</div>
<div id="bbs-seminar-ipd-meta-analysis-of-treatment-covariate-interaction-with-a-continuous-predictor" class="section level1 unnumbered">
<h1 class="unnumbered">18.06.2013: BBS Seminar: IPD meta-analysis of treatment-covariate interaction with a continuous predictor</h1>
<p>No agenda available</p>
<p>No recording available</p>
<table>
<colgroup>
<col width="29%" />
<col width="5%" />
<col width="48%" />
<col width="16%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Willi Sauerbrei, Patrick Royston, Benjamin Kasenda and Matthias Briel</td>
<td align="left"></td>
<td align="left">A method for IPD meta-analysis of treatment-covariate interaction with a continuous predictor in randomised trials</td>
<td align="left"><a href="talks/20130618/1_Sauerbrei.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Willi Sauerbrei and Patrick Royston</td>
<td align="left"></td>
<td align="left">Towards stratified medicine – instead of dichotomization</td>
<td align="left"><a href="talks/20130618/2_Sauerbrei.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Willi Sauerbrei and Patrick Royston</td>
<td align="left"></td>
<td align="left">A new strategy for meta-analysis of continuous covariates in observational studies with IPD</td>
<td align="left"><a href="talks/20130618/3_Sauerbrei.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="joint-bbsefspi-seminar-health-technology-assessment-1" class="section level1 unnumbered">
<h1 class="unnumbered">04.06.2013: Joint BBS/EFSPI Seminar: Health Technology Assessment</h1>
<p><a href="talks/20130604/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="17%" />
<col width="6%" />
<col width="56%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Mike Branson</td>
<td align="left"></td>
<td align="left">Welcome</td>
<td align="left"><a href="talks/20130604/1_Branson.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Fred Sorenson</td>
<td align="left"></td>
<td align="left"> Health Technology Assessment – Why is it so important?</td>
<td align="left"><a href="talks/20130604/2_Sorensen.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Matthias Egger and Mike Chambers</td>
<td align="left"></td>
<td align="left"> Moving HTA forward: The challenges of incorporating real world evidence into Health Technology Assessment</td>
<td align="left"><a href="talks/20130604/3_Egger.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Mike Chambers and Matthias Egger</td>
<td align="left"></td>
<td align="left"> GetReal: Clinical effectiveness in drug development</td>
<td align="left"><a href="talks/20130604/4_Chambers.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Claudia Nicolay</td>
<td align="left"></td>
<td align="left"> Health Technology Assessment – What’s in for Stats?</td>
<td align="left"><a href="talks/20130604/5_Nicolay.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Jens Grüger</td>
<td align="left"></td>
<td align="left"> HTA and personalized healthcare</td>
<td align="left"><a href="talks/20130604/6_Grueger.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Skip Olson</td>
<td align="left"></td>
<td align="left"> HTA – Use of observational</td>
<td align="left"><a href="talks/20130604/7_Olson.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Bruno Falissard</td>
<td align="left"></td>
<td align="left"> The place of subjectivity in the French system (HAS): a good thing or an archaism?</td>
<td align="left"><a href="talks/20130604/8_Falissard.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Ralf Bender</td>
<td align="left"></td>
<td align="left"> Biometrical topics of Health Technology Assessment in Germany</td>
<td align="left"><a href="talks/20130604/9_Bender.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Friedhelm Leverkus</td>
<td align="left"></td>
<td align="left"> 30 Months AMNOG Health Technology Assessment: Outcomes and Issues</td>
<td align="left"><a href="talks/20130604/10_Leverkus.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Lou Garrison</td>
<td align="left"></td>
<td align="left"> HTA in Emerging Markets: A Framework and Examples</td>
<td align="left"><a href="talks/20130604/11_Garrison.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Richard Nixon</td>
<td align="left"></td>
<td align="left"> Using early health economic models to support drug development decisions</td>
<td align="left"><a href="talks/20130604/12_Nixon.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Chrissie Fletcher</td>
<td align="left"></td>
<td align="left"> Using indirect treatment comparisons to support an HTA</td>
<td align="left"><a href="talks/20130604/13_Fletcher.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">All</td>
<td align="left"></td>
<td align="left">Summary of event</td>
<td align="left"><a href="talks/20130604/summary.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-optimal-design-for-non-linear-models" class="section level1 unnumbered">
<h1 class="unnumbered">28.11.2012: BBS Seminar: Optimal Design for Non-linear Models</h1>
<p><a href="talks/20121128/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="23%" />
<col width="52%" />
<col width="14%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Anthony Atkinson</td>
<td align="left">London School of Economics</td>
<td align="left">Experiments for Building Enzyme Kinetic Models</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Tobias Mielke</td>
<td align="left">Aptiv Solutions</td>
<td align="left">Optimal Population Designs for Non-linear Mixed Effects Models</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Barbara Bogacka</td>
<td align="left">Queen Mary College, University of London</td>
<td align="left">Population Optimum Design for Non-linear Mixed Effects Models in the Presence of Covariates</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-benefit-risk-comparative-effectiveness" class="section level1 unnumbered">
<h1 class="unnumbered">25.09.2012: BBS Seminar: Benefit-Risk &amp; Comparative Effectiveness</h1>
<p><a href="talks/20120925/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="16%" />
<col width="5%" />
<col width="58%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Andrea Beyer</td>
<td align="left"></td>
<td align="left">Understanding the risk tolerance of regulatory assessors in Europe: the role of quantitative models in risk communication</td>
<td align="left"><a href="talks/20120925/1_Beyer.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Christoph Dierig and Richard Nixon</td>
<td align="left"></td>
<td align="left">A case study using the BRAT framework for benefit risk assessment</td>
<td align="left"><a href="talks/20120925/2_Dierig.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Christian Hove Rasmussen</td>
<td align="left"></td>
<td align="left">Benefit-risk assessment from a clinical point of view: a structured approach with focus on transparency</td>
<td align="left"><a href="talks/20120925/3_Rasmussen.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Ralf Bender</td>
<td align="left"></td>
<td align="left">Biometrical requirements in (early) benefit assessments</td>
<td align="left"><a href="talks/20120925/4_Bender.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Fred Sorenson</td>
<td align="left"></td>
<td align="left">Benefit-risk assessment and comparative effectiveness research: are they really converging?</td>
<td align="left"><a href="talks/20120925/5_Sorensen.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-emerging-topics-in-pharmaceutical-statistics" class="section level1 unnumbered">
<h1 class="unnumbered">09.07.2012: BBS Seminar: Emerging Topics in Pharmaceutical Statistics</h1>
<p><a href="talks/20120709/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="25%" />
<col width="8%" />
<col width="40%" />
<col width="25%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Stephen A. Julious</td>
<td align="left"></td>
<td align="left">Sample sizes for multiple must-win trials</td>
<td align="left"><a href="talks/20120709/1_Julious.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Eric Derobert</td>
<td align="left"></td>
<td align="left">A parameterized strategy of gatekeeping</td>
<td align="left"><a href="talks/20120709/2_Derobert.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Mouna Akacha &amp; Günther Müller-Velten</td>
<td align="left"></td>
<td align="left">Recurrent event approaches in cardiovascular outcome trials</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Lisa Hampson</td>
<td align="left"></td>
<td align="left">Group sequential tests for delayed responses</td>
<td align="left"><a href="talks/20120709/4_Hampson.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-experiences-in-the-development-and-implementation-of-flexible-designs" class="section level1 unnumbered">
<h1 class="unnumbered">22.05.2012: BBS Seminar: Experiences in the Development and Implementation of Flexible Designs</h1>
<p>No agenda available</p>
<p>No recording available</p>
<p>No slides available</p>
</div>
<div id="bbs-seminar" class="section level1 unnumbered">
<h1 class="unnumbered">29.11.2011: BBS Seminar</h1>
<p><a href="talks/20111129/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="5%" />
<col width="18%" />
<col width="64%" />
<col width="11%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Boris Choy</td>
<td align="left">Business School The University of Sydney</td>
<td align="left">Nonignorable dropout models for longitudinal binary data with random effects: An application of Monte Carlo approximation through the Gibbs output</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Mouna Akacha</td>
<td align="left">Novartis, Basel</td>
<td align="left">Implementing Current Regulatory Guidance on the Treatment of Missing Data: An Industry Perspective</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-fall-conference-current-topics-in-pharmaceutical-statistics-dose-finding-and-multiregional-trials" class="section level1 unnumbered">
<h1 class="unnumbered">16.09.2011: BBS Fall Conference: Current Topics in Pharmaceutical Statistics: Dose Finding and Multiregional Trials</h1>
<p><a href="talks/20110916/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="6%" />
<col width="63%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Andy Grieve</td>
<td align="left"></td>
<td align="left"> Dose Selection in Drug Development: What Can Go Wrong? Can we put it Right?</td>
<td align="left"><a href="talks/20110916/1_Grieve.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Didier Renard</td>
<td align="left"></td>
<td align="left"> Use of modeling &amp; simulation to support design and analysis of a new dose and regimen finding study</td>
<td align="left"><a href="talks/20110916/2_Renard.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Bjoern Bornkamp</td>
<td align="left"></td>
<td align="left"> On the efficiency of two-stage adaptive designs</td>
<td align="left"><a href="talks/20110916/3_Bornkamp.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Georg Gutjahr</td>
<td align="left"></td>
<td align="left">Powerful Modification of Step Down Procedures for Dose Finding</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">H.M. James Hung</td>
<td align="left"></td>
<td align="left"> Planning and Analyzing Multi-regional Clinical Trials: A Regulatory Perspective</td>
<td align="left"><a href="talks/20110916/5_Hung.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Philip Hougaard</td>
<td align="left"></td>
<td align="left"> Global drug development strategies</td>
<td align="left"><a href="talks/20110916/6_Hougaard.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Jorgen Seldrup</td>
<td align="left"></td>
<td align="left"> Designing clinical trials in a multiregional regulatory environment</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Kevin J. Carroll</td>
<td align="left"></td>
<td align="left"> Consistency of treatment effect across regions in a multi-regional trial: reasonable goal or unrealistic requirement?</td>
<td align="left"><a href="talks/20110916/8_Carroll.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-quantitative-benefit-risk-what-matters-to-whom-and-how-getting-the-values-and-weights" class="section level1 unnumbered">
<h1 class="unnumbered">21.07.2011: BBS Seminar Quantitative Benefit-Risk: What Matters to Whom and How? – Getting the Values and Weights</h1>
<p><a href="talks/20110721/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="7%" />
<col width="57%" />
<col width="23%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">John Ferguson</td>
<td align="left"></td>
<td align="left">Structured Benefit-Risk Optimization (BRO): A Framework Quantitative Decision Support Tools</td>
<td align="left"><a href="talks/20110721/1_Ferguson.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Gordon Francis</td>
<td align="left"></td>
<td align="left">Clinical Perspective on Benefit-Risk Assessments</td>
<td align="left"><a href="talks/20110721/2_Francis.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Lawrence Phillips</td>
<td align="left"></td>
<td align="left">Quantitative Benefit-Risk: Determining Values &amp; Assessing Weights</td>
<td align="left"><a href="talks/20110721/3_Phillips.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Andrea Beyer</td>
<td align="left"></td>
<td align="left">Beyond the Probability of Risk: Measuring Perception</td>
<td align="left"><a href="talks/20110721/4_Beyer.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-conference-comparative-quantitative-assessments-benefit-risk-effectiveness" class="section level1 unnumbered">
<h1 class="unnumbered">10.05.2011: BBS Spring Conference: Comparative Quantitative Assessments: Benefit-Risk &amp; Effectiveness</h1>
<p><a href="talks/20110510/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="6%" />
<col width="64%" />
<col width="19%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Chrissie Fletcher</td>
<td align="left"></td>
<td align="left">Industry Perspective on Comparative Effectiveness Research (CER) and the impact of Health Technology Assessment (HTA) in Europe</td>
<td align="left"><a href="talks/20110510/1_Fletcher.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Melvin (Skip) Olson</td>
<td align="left"></td>
<td align="left">Some Issues with Indirect Comparisons</td>
<td align="left"><a href="talks/20110510/2_Olson.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Friedhelm Leverkus</td>
<td align="left"></td>
<td align="left">Health Care Reform in Germany and Update on IQWiG Requirements</td>
<td align="left"><a href="talks/20110510/3_Leverkus.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">John Doyle</td>
<td align="left"></td>
<td align="left">Effect of Comparative Effectiveness Research on Drug Development Innovation: a 360° Appraisal and Summary Discussion</td>
<td align="left"><a href="talks/20110510/4_Doyle.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Deborah Ashby</td>
<td align="left"></td>
<td align="left">Current Methodological Approaches to Benefit-Risk Decision-Making</td>
<td align="left"><a href="talks/20110510/5_Ashby.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">John Ferguson</td>
<td align="left"></td>
<td align="left">Structured Benefit-Risk Optimization (BRO): State-of-the-art and Role of Fully Quantitative Decision Support Tools</td>
<td align="left"><a href="talks/20110510/6_Ferguson.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Michael Forstner</td>
<td align="left"></td>
<td align="left">Considerations for Implementing a Quantitative Benefit-Risk Assessment</td>
<td align="left"><a href="talks/20110510/7_Forstner.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Richard Nixon</td>
<td align="left"></td>
<td align="left">Benefit-Risk Assessment of Multiple Sclerosis Treatments: Lessons Learnt in the use of Multi-Criteria Decision Analysis</td>
<td align="left"><a href="talks/20110510/8_Nixon.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">John Doyle</td>
<td align="left"></td>
<td align="left">Convergence of CER and BRA and Concluding Summary Discussion</td>
<td align="left"><a href="talks/20110510/9_Doyle.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-spring-seminar-multiplicity-in-clinical-trials" class="section level1 unnumbered">
<h1 class="unnumbered">07.05.2011: BBS Spring Seminar: Multiplicity in Clinical Trials</h1>
<p><a href="talks/20110507/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="17%" />
<col width="6%" />
<col width="55%" />
<col width="20%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Huque Mohammad</td>
<td align="left"></td>
<td align="left">Some key multiplicity questions on primary and secondary endpoints of RCCTs and possible answers</td>
<td align="left"><a href="talks/20110507/1_Huque.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Ferber Georg</td>
<td align="left"></td>
<td align="left">Confirmatory statistics in PK/PD studies</td>
<td align="left"><a href="talks/20110507/2_Ferber.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Kornelius Rohmeyer</td>
<td align="left"></td>
<td align="left">gMCP: A GUI for graphical multiple test procedures</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Wolf Michael</td>
<td align="left"></td>
<td align="left">Control of the false discovery rate under dependence using the bootstrap and sub sampling</td>
<td align="left"><a href="talks/20110507/4_Wolf.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Maurer Willi / Glimm Ekkehard</td>
<td align="left"></td>
<td align="left">Multiple and repeated testing of primary</td>
<td align="left"><a href="talks/20110507/5_Maurer.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-statistical-challenges-in-biomedical-research" class="section level1 unnumbered">
<h1 class="unnumbered">13.01.2011: BBS Seminar: Statistical Challenges in Biomedical Research</h1>
<p><a href="talks/20110113/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="7%" />
<col width="57%" />
<col width="24%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Kalisch Markus</td>
<td align="left"></td>
<td align="left"> Can one extract causal information from high-dimensional observational data?</td>
<td align="left"><a href="talks/20110113/1_Kalisch.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Sauerbrei Willi</td>
<td align="left"></td>
<td align="left"> Regression model-building with continuous variables – multivariable fractional polynomials</td>
<td align="left"><a href="talks/20110113/2_Sauerbrei.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-1" class="section level1 unnumbered">
<h1 class="unnumbered">30.11.2010: BBS Seminar</h1>
<p><a href="talks/20101130/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="8%" />
<col width="61%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Harald Binder</td>
<td align="left"></td>
<td align="left">Fitting and evaluating risk prediction models with high-dimensional molecular data</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Martin Wolkewitz</td>
<td align="left"></td>
<td align="left">Healthcare epidemiology hospital-acquired infections statistical modeling of outbreaks</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-fall-conference" class="section level1 unnumbered">
<h1 class="unnumbered">04.10.2010: BBS Fall Conference</h1>
<p><a href="talks/20101004/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="18%" />
<col width="9%" />
<col width="56%" />
<col width="15%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Helmut Schäfer</td>
<td align="left">University of Marburg</td>
<td align="left">Optimized and flexible designs for genome-wide associations studies</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Maximo Carreras</td>
<td align="left">Roche, Basel</td>
<td align="left">Point Estimation in Two-Stage Adaptive Designs With Mid-Trial Treatment Selection</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">David Lawrence</td>
<td align="left">Novartis, Basel</td>
<td align="left">The A to Z of DMC interaction in a phase II/III adaptive design with treatment selection</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Reinhard Eisebitt</td>
<td align="left">ClinResearch</td>
<td align="left">Methods to protect the blinding, including controlled emergency unblinding, in adaptive design trials with flexible randomization schemes</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Tim Friede</td>
<td align="left">University of Göttingen</td>
<td align="left">The role of DMCs in adaptive design trials: The perspective of a DMC member</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Sue-Jane Wang</td>
<td align="left">FDA</td>
<td align="left">Adaptive Design Consideration: A Regulatory Perspective on How to Maintain Validity and Integrity of Trials</td>
<td align="left"><a href="talks/20101004/6_Wang.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">James Hung</td>
<td align="left">FDA</td>
<td align="left">Emerging Challenges in Design and Analysis of Non-inferiority Trials</td>
<td align="left"><a href="talks/20101004/7_Hung.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Franz König</td>
<td align="left">EMA</td>
<td align="left"></td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Ralf Bender</td>
<td align="left">IQWiG</td>
<td align="left">The importance of Non-inferiority testing in benefit assessments of medical interventions</td>
<td align="left"><a href="talks/20101004/9_Bender.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Heinz Schmidli</td>
<td align="left">Novartis, Basel</td>
<td align="left">Estimating the placebo-effect in a non-inferiority trial: a case study</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Georg Gutjahr, Werner Brannath, Peter Bauer</td>
<td align="left">Bremen and Vienna</td>
<td align="left">Unblinded SampleSize Modification for Fisher’s Exact Test</td>
<td align="left"><a href="talks/20101004/11_Gutjahr.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbsefspi-european-statistical-meeting-on-oncology" class="section level1 unnumbered">
<h1 class="unnumbered">24.06.2010: BBS/EFSPI European Statistical Meeting on Oncology</h1>
<p><a href="talks/20100624/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="20%" />
<col width="52%" />
<col width="16%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Bertil Jonsson</td>
<td align="left">Medical Products Agency</td>
<td align="left">Understanding Progression-free Survival</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Marc Buyse</td>
<td align="left">IDDI and University of Hasselt</td>
<td align="left">The Time to Progression Ratio for Phase II Trials of Personalized Medicine</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Stuart Bailey</td>
<td align="left">Novartis, Basel</td>
<td align="left">Adaptive Bayesian Designs for Phase I Oncology Trials</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Simon Wandel</td>
<td align="left">Novartis, Basel</td>
<td align="left">Bayesian Hierarchical Modelling of Clinical Response in NSCLC Subpopulations</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Claire Watkins</td>
<td align="left">AstraZeneca</td>
<td align="left">IRESSA: A Journey of Experience from Broad to Biomarker Populations</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Cong Chen</td>
<td align="left">Merck</td>
<td align="left">Optimal Cost-Effective Go-No Go Decisions in Late-Stage Oncology Drug Development</td>
<td align="left">No presentation available</td>
</tr>
<tr class="odd">
<td align="left">Jonas Wiedemann</td>
<td align="left">Roche, Basel</td>
<td align="left">Oncology Dose Finding – A Case Study</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-epidemiology" class="section level1 unnumbered">
<h1 class="unnumbered">28.04.2010: BBS Seminar Epidemiology</h1>
<p><a href="talks/20100428/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="11%" />
<col width="33%" />
<col width="38%" />
<col width="17%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Noah Jamie Robinson</td>
<td align="left">Roche, Basel</td>
<td align="left">Epidemiology: the basics and in practice (at Roche)</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Jim Young</td>
<td align="left">Basel Institute for Clinical Epidemiology and Biostatistics</td>
<td align="left">Approximate Bayesian methods for the analysis of epidemiological data</td>
<td align="left"><a href="talks/20100428/2_Young">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-2" class="section level1 unnumbered">
<h1 class="unnumbered">12.03.2010: BBS Seminar</h1>
<p>No agenda available</p>
<p>No recording available</p>
<table>
<colgroup>
<col width="9%" />
<col width="6%" />
<col width="61%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Benda Norbert</td>
<td align="left"></td>
<td align="left">The use of adaptive designs in dose finding studies</td>
<td align="left"><a href="talks/20100312/1_Benda.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Brannath Werner</td>
<td align="left"></td>
<td align="left">Challenges in the application of adaptive phase II/III designs in oncology</td>
<td align="left"><a href="talks/20100312/2_Brannath.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Fleischer Frank</td>
<td align="left"></td>
<td align="left">Statistical modeling in the context of progression-free survival</td>
<td align="left"><a href="talks/20100312/3_Fleischer.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Friede Tim</td>
<td align="left"></td>
<td align="left">Blinded sample size reestimation with count data</td>
<td align="left"><a href="talks/20100312/4_Friede.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Glimm Ekkehard</td>
<td align="left"></td>
<td align="left">Some lessons learned from designing and adaptive clinical trial with time-to-event as the primary endpoint</td>
<td align="left"><a href="talks/20100312/5_Glimm.pdf">link</a></td>
</tr>
<tr class="even">
<td align="left">Guthjahr Georg</td>
<td align="left"></td>
<td align="left">Multiple Type I error control in response adaptive Phase II/III designs with treatment selection</td>
<td align="left"><a href="talks/20100312/6_Gutjahr.pdf">link</a></td>
</tr>
<tr class="odd">
<td align="left">Wang Sue-Jane</td>
<td align="left"></td>
<td align="left">U.S. FDA Draft Guidance on Adaptive Design Clinical Trials – Statistical Considerations and Issues</td>
<td align="left"><a href="talks/20100312/7_Wang.pdf">link</a></td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-enhanced-statistical-methodology" class="section level1 unnumbered">
<h1 class="unnumbered">12.01.2010: BBS Seminar: Enhanced Statistical Methodology</h1>
<p><a href="talks/20100112/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="13%" />
<col width="18%" />
<col width="45%" />
<col width="22%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Leonhard Held</td>
<td align="left">University of Zürich</td>
<td align="left">A Nomogram for P Values</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Kaspar Rufibach</td>
<td align="left">University of Zürich</td>
<td align="left">Estimation of two ordered monotone regression curves</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-challenges-and-evaluation-of-biomarkers" class="section level1 unnumbered">
<h1 class="unnumbered">07.12.2009: BBS Seminar: Challenges and Evaluation of Biomarkers</h1>
<p><a href="talks/20091207/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="12%" />
<col width="10%" />
<col width="60%" />
<col width="17%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Eric Holmgren</td>
<td align="left">Genentech</td>
<td align="left">Quantifying the usefulness of PD biomarkers in phase 2 screening trials of oncology drugs</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Martin Schumacher</td>
<td align="left">Novartis, Basel</td>
<td align="left">Class prediction with gene expression data</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>
<div id="bbs-seminar-operational-and-implementation-considerations-in-adaptive-designs" class="section level1 unnumbered">
<h1 class="unnumbered">26.10.2009: BBS Seminar: Operational and Implementation Considerations in Adaptive Designs</h1>
<p><a href="talks/20091026/agenda.pdf">Agenda</a></p>
<p>No recording available</p>
<table>
<colgroup>
<col width="10%" />
<col width="16%" />
<col width="54%" />
<col width="18%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">Speaker</th>
<th align="left">Institution</th>
<th align="left">Title</th>
<th align="left">Download slides</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">Eva Miller</td>
<td align="left">ICON Clinical Research</td>
<td align="left">Logistical Considerations in the Implementation of Adaptive Trial Designs</td>
<td align="left">No presentation available</td>
</tr>
<tr class="even">
<td align="left">Norbert Benda</td>
<td align="left">Novartis, Basel</td>
<td align="left">Considerations and Experiences in Adaptive Dose Finding</td>
<td align="left">No presentation available</td>
</tr>
</tbody>
</table>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
